High mobility group nucleosomal binding domain 2 pseudogene 11 (HMGN2P11)

High mobility group nucleosomal binding domain 2 pseudogene 11 (HMGN2P11) is a human pseudogene, meaning it is a sequence that has homology to a functional gene (such as HMGN2) but cannot generate a functional protein product due to accumulated mutations or deletions[4][5][6]. Pseudogenes in general can have regulatory effects on gene expression, often by acting as competing endogenous RNAs (ceRNAs) or sources of small RNAs, but there is no published evidence that HMGN2P11 itself is therapeutically targeted or has established functions in disease or drug action[2][3][6]. Common aliases include 28H, HMG17P1, and HMGN2L11[5]. It is not considered a drug target, receptor, or therapeutic target in any context.

Other names

28HHMG17P1HMGN2L11